Juluca

Juluca

  • June 2019 •
  • 14 pages •
  • Report ID: 5807940 •
  • Format: PDF
Juluca ([dolutegravir + rilpivirine]; ViiV Healthcare/Johnson and Johnson) is a single-tablet regimen approved in the US for the treatment of patients infected with HIV-1 who have achieved viral suppression.